首页 > 市场调查报告书 > 医疗设备

透析机设备

市场调查报告书

商品编码

1439219

全球连续性肾臟替代治疗设备 (CRRT) 市场：洞察、竞争格局、市场预测：2030 年

Continuous Renal Replacement Therapy Machines (CRRT) - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 2024年02月01日 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

简介目录图表

2023年全球连续性肾臟替代治疗（CRRT）设备市场规模为12.5亿美元。预计到 2030 年，该市场将达到 19.2 亿美元，2024-2030 年预测期间复合年增长率为 7.39%。全球范围内急性肾衰竭或急性肾损伤(AKI) 盛行率不断上升，以及发生AKI 的ICU 患者负担随着脓毒症发病率的增加而增加，推动了对CRRT 设备的需求。这在很大程度上归功于重大的技术进步在产品线。 CRRT 相对于间歇性血液净化系统的临床优势也是 CRRT 设备市场的一个突出驱动因素。

急性肾损伤（AKI）是所有住院患者最常见的严重併发症之一，其发生率在住院患者尤其是重症监护病房的患者中呈上升趋势。此外，潜在的慢性肾臟疾病被认为是 AKI 的危险因子。此外，根据 2020 年《刺胳针》发表的一项研究，2017 年记录了 6.975 亿个各阶段 CKD 病例，约 120 万人因此死亡。透过 CRRT 设备进行适当和及时的治疗可能会降低慢性肾损伤盛行率和相关死亡率的增加。对于血流动力学不稳定的 AKI 重症患者，CRRT 设备透过在 24 小时内缓慢清除体液和尿毒症毒素并将清洁的血液送回体内来支持肾臟。因此，有助于 CRRT 全球市场的成长。

此外，自连续性肾臟替代疗法出现以来，以高渗透压血液滤过和高容量渗透性为主的各种技术进步也有望推动全球 CRRT 市场的发展。

目前，製造商正在开发精密设备，在 CRRT 手术期间提供安全可靠的效能。此外，这些仪器配备了易于使用的介面，可轻鬆进行操作。例如，最近在 2022 年，百特宣布推出 PrisMax 2，这是其下一代 CRRT 平台的最新版本。 PrisMax 2 系统采用了该公司TrueVue 数位健康产品组合中的新解决方案，可简化连续肾臟替代疗法(CRRT) 和其他器官支持疗法的实施，同时还改进了重症监护病房(ICU) 的性能，旨在让医院能够灵活地满足他们的独特需求。这些因素正在推动全球 CRRT 设备市场的扩张。

本报告调查了全球连续性肾臟替代治疗设备 (CRRT) 市场，并按产品类型、模式、患者、最终用户、地区和市场渗透率提供了市场概述。我们提供公司配置文件等等。

Continuous Renal Replacement Therapy (CRRT) Machines Market By Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult And Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography is projected to grow at a constant CAGR during the forecast period from 2024-2030 on account of significant technological advancement and rising prevalence of acute renal failure.

Global Continuous Renal Replacement Therapy (CRRT) Machines Market was valued at USD 1.25 billion in 2023, growing at a CAGR of 7.39% during the forecast period from 2024 to 2030, to reach USD 1.92 billion by 2030. The demand for CRRT machines is predominantly attributed to the rise in the prevalence of acute renal failure or Acute Kidney Injury (AKI) across the globe, the growing burden of ICU patients with AKI along with an increase in the incidence of sepsis, significant technological advancements in the product line. The clinical advantage of CRRT over intermittent blood purification systems is also a prominent driving factor for the CRRT machines market.

CRRT Machines Market Dynamics:

Acute kidney injury (AKI) is one of the most common serious complications for all hospital admissions, with its incidence increasing among hospitalized patients, particularly those in the intensive care unit. Moreover, it is recognized that underlying chronic kidney disease is a risk factor for AKI. Also, according to a study published in LANCET 2020, in 2017, 697.5 million cases of all-stage CKD were recorded and around 1.2 million died from the indication. The rising prevalence of chronic kidney disorders and their associated deaths could have been reduced through proper and timely treatment through CRRT machines as these machines provide renal support by slowly removing fluid and uremic toxins and returning clean blood to the body over 24 hours duration in critically ill patients suffering from AKI and are hemodynamically unstable. Thus, contributing to the growth of the Global CRRT market.

Furthermore, various technological advancement which mainly comprises high permeability hemofiltration and high volume permeability since the advent of continuous renal replacement therapy is also expected to boost the global CRRT market.

At present, manufacturers are developing precise devices that are safe and give reliable performance during CRRT procedures. Also, for easy performance, these devices are equipped with a user-friendly interface. For instance, recently, in 2022, Baxter announced the launch of its latest version of the next-generation CRRT platform, PrisMax 2. The PrisMax 2 system features new solutions within the company's TrueVue digital health portfolio and is designed to help simplify the delivery of continuous renal replacement therapy (CRRT) and other organ support therapies while providing hospitals the flexibility to meet the unique demands of the intensive care unit (ICU). Thus, such factors are contributing to the upsurge of the global CRRT machines market.

However, certain factors such as the high procedural cost of CRRT are likely to pose a minor hurdle to the growth of the CRRT market.

CRRT Machines Market Segment Analysis:

CRRT Market By Product Type (Machines and Consumables), Modality (Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF)), Patient (Adult and Pediatric), End-User (Hospitals, Dialysis Centres, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the CRRT market modality segment, Continuous Venovenous Hemofiltration (CVVH) holds the highest market. This is owing to the rising incidence of fluid overloads that are frequently found in patients with acute kidney injuries and in the ICU. However, it is also expected that Continuous Venovenous Hemodiafiltration (CVVHDF) will observe lucrative growth during the forecasted period. This is because the CVVHDF treatment modality results in the complete removal of solutes and fluids from the blood as it combines both the principle of convection and diffusion i.e., hemofiltration and hemodialysis by making use of a highly efficient hemofilter for the removal of solute and fluid. Thereby propelling the segmental growth of the CRRT market.

Moreover, most of CRRT machines are compatible with more than two or three modalities which can further fuel the market. In 2019, Baxter launched PrisMax system the company's platform for continuous renal replacement therapy (CRRT), therapeutic plasma exchange (TPE), and organ support therapies (OST). The system delivers all therapy modalities of CRRT and therapeutic plasma exchange (TPE) without additional equipment. Hence, these factors are responsible for the growth of the CVVH modality systems along with CVVHDF modalities during the forecasted period.

North America is expected to dominate the overall CRRT Machines Market:

Among all the regions, North America is expected to dominate the overall CRRT machines market during the forecast period. This domination is due to the growing demand for advanced technologies in CRRT machines, the increasing cases of CKD and associated AKIs in the region are driving regional growth.

Further, the United States represents the largest market worldwide supported by developed healthcare infrastructure and strong R&D expenditure by the key players. Rising product launch and commercialization agreements among the key manufacturers are also anticipated to boost the CRRT market. For instance, the recent launch of the first and only Pediatric and Neonatal Acute Dialysis Machine (Carpediem(TM) systems) in December 2020 which is intended to provide continuous renal replacement therapy (CRRT) to patients weighing between 2.5 and 10 kilograms in the United States is likely to grow the market in the region.

In addition, the integration of telehealth platforms to improve outcomes and the care experience for CKD patients deciding to treat at home is also expected to fuel the market in the region. For instance, in 2019, DaVita incorporated its connective technologies DaVita Care Connect into its home dialysis program to meet the latest COVID-19 regulations implemented by the government to prevent the transmission of infection.

Europe and Asia-Pacific region have the future potential growth for global CRRT machines. This is due to the increasing incidence and prevalence of AKI and rising government initiatives to increase awareness about the advancements in renal therapy which is likely to surge the market. According to the International Society of Nephrology 2022, every year, there are around 13.3 million cases of AKI and the burden is specifically high in emerging countries where the annual incidence is estimated to be 11.3 million.

Therefore, this situation is giving rise to a critical need for CRRT machines thereby augmenting the CRRT market in this region. Moreover, rapid urbanization, an increase in disposable income in emerging countries such as China, India, and others, and the presence of local manufacturers in the region are also projected to drive the global CRRT market.

CRRT Machines Market Key Players:

Some of the key market players operating in the CRRT machines market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Informed SA, Medtronic, and others.

Recent Developmental Activities in CRRT Machines Market:

In August 2020, Baxter obtained US FDA Emergency Use Authorization for Regiocit Replacement Solution used In CRRT.

In April 2020, Fresenius Medical Care received US FDA Emergency Use Authorization for multiFiltrate PRO System and multiBic/multiPlus Solutions to provide CRRT to treat patients in an acute care environment during the COVID-19 pandemic.

Key Takeaways from the CRRT Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the CRRT machines market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the Global CRRT machines Market.

Various opportunities available for the other competitor in the CRRT machines Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for CRRT Machines market growth in the coming future?

Target Audience who can be benefited from CRRT Machines Market Report Study

CRRT machines providers

Research organizations and consulting companies

CRRT machines-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in CRRT Machines

Various End-users who want to know more about the CRRT machines Market and latest technological developments in the CRRT machines market.

Frequently Asked Questions for CRRT Machines Market

What is CRRT Machine?

CRRT machines are used in blood purification therapy in patients suffering with acute renal failure or acute kidney injuries. The machine pumps and controls the rate of blood flow and includes software to safely monitor therapy delivery. These machines are available in four different modes: Slow Continuous Ultrafiltration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemodiafiltration (CVVHDF.

What are the drivers for the Global CRRT Machines Market?

The major factors fuelling the demand for CRRT machines are the rising prevalence of acute renal failure, the growing burden of acute kidney injuries among ICU patients, new product approvals, and the shifting focus of key players for developing advanced products.

What is the market for Global CRRT Machines?

What are the key players operating in the global CRRT Machines Market?

What regions have the highest share in the CRRT Machines market?

North America is expected to dominate the overall CRRT Machines market during the forecast period, 2024 to 2030 due to the advanced healthcare system, increasing prevalence of chronic kidney disorders in the region, and rising product developmental activities among the key market players.

1. CRRT Machines Market Report Introduction

2. CRRT Machines Market Executive Summary

2.1. Scope of the Study
2.2. Market at a Glance
2.3. Competitive Assessment

3. Regulatory Analysis

3.1. The United States
3.2. Europe
3.3. Japan
3.4. China

4. CRRT Machines Market Key Factor Analysis

4.1 CRRT Machines Market Drivers
- 4.1.1 Increasing Incidence of Acute Kidney Injury (AKI)
- 4.1.2 Increasing Clinical Advantage of CRRT Over Intermittent Blood Purification
- 4.1.3 Technological Advancement and New Product Launches
- 4.1.4 Growing Number of ICU Patients with AKI
4.2 CRRT Machines Market Restraints and Challenges
- 4.2.1 Stringent Regulatory Guidelines
- 4.2.2 High Procedural Cost of CRRT
4.3 CRRT Machines Market Opportunities
- 4.3.1 Development of CRRT Systems for Pediatric Patients
- 4.3.2 Growth Opportunities in emerging countries

5. CRRT Machines Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry

6. CRRT Machines Market layout

6.1 By Product Type
- 6.1.1 Machines
- 6.1.2 Consumables
6.2 By Modality
- 6.2.1 Slow Continuous Ultrafiltration (SCUF)
- 6.2.2 Continuous Venovenous Hemofiltration (CVVH)
- 6.2.3 Continuous Venovenous Hemodialysis (CVVHD)
- 6.2.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
6.3 By Patient
- 6.3.1 Adults
- 6.3.2 Pediatrics
6.4 By End-User
- 6.4.1 Hospitals
- 6.4.2 Dialysis Centers
- 6.4.3 Others
6.5 By Geography
- 6.5.1 North America CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.1.1. United States CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.1.2. Canada CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.1.3. Mexico CRRT Machines Market Size in USD million (2021-2030)
- 6.5.2 Europe CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.1 France CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.2 Germany CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.3 United Kingdom CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.4 Italy CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.5 Spain CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.2.6 Rest of Europe CRRT Machines Market Size in USD million (2021-2030)
- 6.5.3 Asia-Pacific CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.1 China CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.2 Japan CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.3 India CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.4 Australia CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.5 South Korea CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.3.6 Rest of Asia-Pacific CRRT Machines Market Size in USD million (2021-2030)
- 6.5.4 Rest of the World (RoW) CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.4.1 Middle East CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.4.2 Africa CRRT Machines Market Size in USD million (2021-2030)
  - 6.5.4.3 South America CRRT Machines Market Size in USD million (2021-2030)

7. CRRT Machines Company and Product Profiles

7.1 Baxter International Inc.
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
7.2 Fresenius Medical Care AG & Co. KGaA
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
7.3 NIKKISO CO., LTD.
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
7.4 B. Braun Melsungen AG
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
7.5 Asahi Kasei Corporation
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
7.6 Infomed SA
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
7.7 Medtronic
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
7.8 NxStage Medical, Inc.
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
7.9 Medica S.p.A.
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
7.10 SWS Hemodialysis Care Co., Ltd.
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
7.11 Dialco Medical Inc.
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
7.12 Anjue Medical Equipment Co. Ltd.
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
7.13 Medica S.p.A.
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
7.14 Jiangxi Sanxin Medtec Co. Ltd.
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy